|
|
|
Stem Cell Related Patent Number US5434340
| Title: | Transgenic mice depleted in mature T-cells and methods for making transgenic mice | | Inventors: | Krimpenfort, Paulus J. A.; Amsterdam, Netherlands
Berns, Antonius J. M.; Spaarndam, Netherlands | | Summary: | This invention introduces a transgenic nonhuman mammal which is depleted of mature lymphocyte cells, methods and uses thereof. Described herein are transgenic mice produced by a transgene which encodes a lymphatic polypeptide variant to inhibit formation, such that the transgenic mice exhibit a phenotype characterized by the substantial depletion of a mature T lymphocytic cell type otherwise naturally occurring in the species from which the transgenic mouse is derived. Further disclosed are properties of the transgenic mouse having a phenotype characterized by the substantial absence of mature T-cells, wherein the phenotype is conferred by a transgene contained in the somatic and germ cells of the mouse such that the transgene comprises a DNA fragment which encodes a T-cell receptor ?-chain polypeptide variant which is incapable of mediating T-cell maturation in the transgenic mouse. Further claims of the invention include a carboxy-terminal portion of the T-cell receptor ?-chain encoded by the transgene which comprises the constant region of the T-cell receptor ?-chain. Therapeutic applications for the use of such transgenic mice in the treatment of a variety of human diseases are included. This invention represents a continuation of other applications filed by the same assignee and inventors. | | Abstract: | Transgenic mice having a phenotype characterized by the substantial absence of mature T lymphocytes otherwise naturally occurring in said mice. The phenotype is conferred in the transgenic mouse by a transgene contained in at least the precursor stem cell of the T lymphocyte which is depleted. The transgene comprises a DNA sequence encoding a T cell receptor polypeptide variant which inhibits maturation of the T lymphocyte. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US5434340 | | Application Number: | US1992000919936 | | Date Filed: | 27/07/1992 | | Date Published: | 18/07/1995 | | Assignee: | GenPharm International, Inc., Mountain View, CA, USA |
|
|
